nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—panic disorder—Bupropion—obesity	0.282	1	CpDpCtD
Maprotiline—Atomoxetine—Benzphetamine—obesity	0.075	1	CrCrCtD
Maprotiline—HTR2C—obesity	0.0681	0.406	CbGaD
Maprotiline—DRD2—obesity	0.0561	0.335	CbGaD
Maprotiline—HTR2A—obesity	0.0434	0.259	CbGaD
Maprotiline—SLC6A3—Diethylpropion—obesity	0.0309	0.0955	CbGbCtD
Maprotiline—SLC6A3—Sibutramine—obesity	0.0234	0.0724	CbGbCtD
Maprotiline—SLC6A3—Phendimetrazine—obesity	0.0234	0.0724	CbGbCtD
Maprotiline—SLC6A2—Diethylpropion—obesity	0.0226	0.0699	CbGbCtD
Maprotiline—SLC6A3—Benzphetamine—obesity	0.0177	0.0548	CbGbCtD
Maprotiline—SLC6A3—Phentermine—obesity	0.0177	0.0548	CbGbCtD
Maprotiline—SLC6A2—Phendimetrazine—obesity	0.0171	0.053	CbGbCtD
Maprotiline—SLC6A2—Sibutramine—obesity	0.0171	0.053	CbGbCtD
Maprotiline—SLC6A3—Phenylpropanolamine—obesity	0.0169	0.0523	CbGbCtD
Maprotiline—ORM1—Bupropion—obesity	0.0159	0.0493	CbGbCtD
Maprotiline—SLC6A3—Bupropion—obesity	0.0151	0.0466	CbGbCtD
Maprotiline—SLC6A3—Methamphetamine—obesity	0.0142	0.0438	CbGbCtD
Maprotiline—SLC6A2—Phentermine—obesity	0.013	0.0401	CbGbCtD
Maprotiline—SLC6A2—Benzphetamine—obesity	0.013	0.0401	CbGbCtD
Maprotiline—SLC6A2—Phenylpropanolamine—obesity	0.0124	0.0383	CbGbCtD
Maprotiline—SLC6A2—Bupropion—obesity	0.011	0.0341	CbGbCtD
Maprotiline—SLC6A2—Methamphetamine—obesity	0.0104	0.0321	CbGbCtD
Maprotiline—CYP1A2—Phentermine—obesity	0.00472	0.0146	CbGbCtD
Maprotiline—CYP1A2—Phenylpropanolamine—obesity	0.0045	0.0139	CbGbCtD
Maprotiline—CYP1A2—Bupropion—obesity	0.00401	0.0124	CbGbCtD
Maprotiline—CYP2D6—Phentermine—obesity	0.00389	0.012	CbGbCtD
Maprotiline—CYP2D6—Bupropion—obesity	0.00331	0.0102	CbGbCtD
Maprotiline—CYP2D6—Methamphetamine—obesity	0.00311	0.00962	CbGbCtD
Maprotiline—CYP1A2—Cimetidine—obesity	0.00295	0.00911	CbGbCtD
Maprotiline—ABCB1—Cimetidine—obesity	0.00258	0.00797	CbGbCtD
Maprotiline—CYP2D6—Cimetidine—obesity	0.00243	0.00751	CbGbCtD
Maprotiline—ORM1—bile—obesity	0.00203	0.0922	CbGeAlD
Maprotiline—CHRM3—muscle of abdomen—obesity	0.00186	0.0845	CbGeAlD
Maprotiline—SLC6A2—sympathetic nervous system—obesity	0.00151	0.0687	CbGeAlD
Maprotiline—HTR7—sympathetic nervous system—obesity	0.00146	0.0662	CbGeAlD
Maprotiline—HTR7—vagus nerve—obesity	0.00141	0.0642	CbGeAlD
Maprotiline—SLC6A2—autonomic nervous system—obesity	0.00102	0.0462	CbGeAlD
Maprotiline—HTR7—autonomic nervous system—obesity	0.00098	0.0445	CbGeAlD
Maprotiline—HTR2A—sympathetic nervous system—obesity	0.000909	0.0413	CbGeAlD
Maprotiline—HTR2A—vagus nerve—obesity	0.00088	0.04	CbGeAlD
Maprotiline—HTR2A—autonomic nervous system—obesity	0.000611	0.0278	CbGeAlD
Maprotiline—ORM1—gall bladder—obesity	0.000563	0.0256	CbGeAlD
Maprotiline—SLC6A3—hindbrain—obesity	0.000531	0.0241	CbGeAlD
Maprotiline—HTR7—hindbrain—obesity	0.000413	0.0188	CbGeAlD
Maprotiline—DRD2—hindbrain—obesity	0.00039	0.0177	CbGeAlD
Maprotiline—Atomoxetine—NPY1R—obesity	0.000326	0.195	CrCbGaD
Maprotiline—SLC6A3—respiratory system—obesity	0.000324	0.0147	CbGeAlD
Maprotiline—SLC6A2—respiratory system—obesity	0.000262	0.0119	CbGeAlD
Maprotiline—HTR2A—hindbrain—obesity	0.000257	0.0117	CbGeAlD
Maprotiline—HTR7—respiratory system—obesity	0.000252	0.0115	CbGeAlD
Maprotiline—CHRM2—cardiovascular system—obesity	0.000249	0.0113	CbGeAlD
Maprotiline—DRD2—respiratory system—obesity	0.000238	0.0108	CbGeAlD
Maprotiline—CYP2D6—hindbrain—obesity	0.000234	0.0107	CbGeAlD
Maprotiline—CHRM1—cardiovascular system—obesity	0.000227	0.0103	CbGeAlD
Maprotiline—CYP1A2—respiratory system—obesity	0.000201	0.00914	CbGeAlD
Maprotiline—HTR7—cardiovascular system—obesity	0.000193	0.00877	CbGeAlD
Maprotiline—Sertraline—SLC6A4—obesity	0.00019	0.114	CrCbGaD
Maprotiline—HRH1—respiratory system—obesity	0.000188	0.00855	CbGeAlD
Maprotiline—ORM1—endocrine gland—obesity	0.000183	0.00832	CbGeAlD
Maprotiline—CHRM3—adipose tissue—obesity	0.000179	0.00813	CbGeAlD
Maprotiline—CHRM2—endocrine gland—obesity	0.000171	0.00776	CbGeAlD
Maprotiline—CHRM3—digestive system—obesity	0.000168	0.00765	CbGeAlD
Maprotiline—ORM1—liver—obesity	0.000165	0.00751	CbGeAlD
Maprotiline—DRD2—pituitary gland—obesity	0.000162	0.00735	CbGeAlD
Maprotiline—HTR7—digestive system—obesity	0.00016	0.00728	CbGeAlD
Maprotiline—SLC6A2—adrenal gland—obesity	0.000158	0.0072	CbGeAlD
Maprotiline—HTR2A—respiratory system—obesity	0.000157	0.00714	CbGeAlD
Maprotiline—CHRM1—endocrine gland—obesity	0.000155	0.00707	CbGeAlD
Maprotiline—HTR7—adrenal gland—obesity	0.000153	0.00694	CbGeAlD
Maprotiline—CHRM3—endocrine gland—obesity	0.000139	0.00632	CbGeAlD
Maprotiline—SLC6A2—endocrine gland—obesity	0.000137	0.00624	CbGeAlD
Maprotiline—HTR7—endocrine gland—obesity	0.000132	0.00602	CbGeAlD
Maprotiline—CYP1A2—digestive system—obesity	0.000128	0.00581	CbGeAlD
Maprotiline—HRH1—adipose tissue—obesity	0.000127	0.00578	CbGeAlD
Maprotiline—DRD2—endocrine gland—obesity	0.000125	0.00569	CbGeAlD
Maprotiline—HTR2A—cardiovascular system—obesity	0.00012	0.00547	CbGeAlD
Maprotiline—HRH1—digestive system—obesity	0.00012	0.00544	CbGeAlD
Maprotiline—HTR7—liver—obesity	0.000119	0.00543	CbGeAlD
Maprotiline—HRH1—adrenal gland—obesity	0.000114	0.00518	CbGeAlD
Maprotiline—ABCB1—islet of Langerhans—obesity	0.000109	0.00496	CbGeAlD
Maprotiline—Protriptyline—SLC6A4—obesity	0.000109	0.0653	CrCbGaD
Maprotiline—HTR2A—pituitary gland—obesity	0.000107	0.00485	CbGeAlD
Maprotiline—CYP1A2—endocrine gland—obesity	0.000106	0.0048	CbGeAlD
Maprotiline—ABCB1—respiratory system—obesity	0.000103	0.00468	CbGeAlD
Maprotiline—HTR2A—digestive system—obesity	9.99e-05	0.00454	CbGeAlD
Maprotiline—HRH1—endocrine gland—obesity	9.89e-05	0.00449	CbGeAlD
Maprotiline—Metixene—HTR2C—obesity	9.82e-05	0.0588	CrCbGaD
Maprotiline—HTR2A—adrenal gland—obesity	9.52e-05	0.00433	CbGeAlD
Maprotiline—CYP1A2—liver—obesity	9.52e-05	0.00433	CbGeAlD
Maprotiline—CYP2D6—digestive system—obesity	9.1e-05	0.00414	CbGeAlD
Maprotiline—ABCB1—adrenal cortex—obesity	8.64e-05	0.00393	CbGeAlD
Maprotiline—Tinnitus—Sibutramine—obesity	8.43e-05	0.00116	CcSEcCtD
Maprotiline—Mediastinal disorder—Orlistat—obesity	8.42e-05	0.00116	CcSEcCtD
Maprotiline—Sleep disorder—Topiramate—obesity	8.39e-05	0.00115	CcSEcCtD
Maprotiline—Dizziness—Diethylpropion—obesity	8.36e-05	0.00115	CcSEcCtD
Maprotiline—HTR2A—endocrine gland—obesity	8.26e-05	0.00375	CbGeAlD
Maprotiline—Alopecia—Orlistat—obesity	8.26e-05	0.00113	CcSEcCtD
Maprotiline—Diarrhoea—Cimetidine—obesity	8.23e-05	0.00113	CcSEcCtD
Maprotiline—Angiopathy—Sibutramine—obesity	8.2e-05	0.00113	CcSEcCtD
Maprotiline—Malnutrition—Orlistat—obesity	8.13e-05	0.00112	CcSEcCtD
Maprotiline—Disorientation—Topiramate—obesity	8.11e-05	0.00111	CcSEcCtD
Maprotiline—Vascular purpura—Topiramate—obesity	8.11e-05	0.00111	CcSEcCtD
Maprotiline—Arrhythmia—Sibutramine—obesity	8.08e-05	0.00111	CcSEcCtD
Maprotiline—Vomiting—Diethylpropion—obesity	8.03e-05	0.0011	CcSEcCtD
Maprotiline—Alopecia—Sibutramine—obesity	7.99e-05	0.0011	CcSEcCtD
Maprotiline—Nasal congestion—Topiramate—obesity	7.97e-05	0.00109	CcSEcCtD
Maprotiline—Rash—Diethylpropion—obesity	7.97e-05	0.00109	CcSEcCtD
Maprotiline—Dysgeusia—Orlistat—obesity	7.96e-05	0.00109	CcSEcCtD
Maprotiline—Dermatitis—Diethylpropion—obesity	7.96e-05	0.00109	CcSEcCtD
Maprotiline—Dizziness—Cimetidine—obesity	7.95e-05	0.00109	CcSEcCtD
Maprotiline—Headache—Diethylpropion—obesity	7.92e-05	0.00109	CcSEcCtD
Maprotiline—ABCB1—cardiovascular system—obesity	7.89e-05	0.00359	CbGeAlD
Maprotiline—Hepatitis—Bupropion—obesity	7.88e-05	0.00108	CcSEcCtD
Maprotiline—Malnutrition—Sibutramine—obesity	7.87e-05	0.00108	CcSEcCtD
Maprotiline—Hallucination—Bupropion—obesity	7.84e-05	0.00108	CcSEcCtD
Maprotiline—Hypoaesthesia—Bupropion—obesity	7.84e-05	0.00108	CcSEcCtD
Maprotiline—Libido decreased—Topiramate—obesity	7.83e-05	0.00108	CcSEcCtD
Maprotiline—Urinary tract disorder—Bupropion—obesity	7.78e-05	0.00107	CcSEcCtD
Maprotiline—Hot flush—Topiramate—obesity	7.76e-05	0.00107	CcSEcCtD
Maprotiline—Urethral disorder—Bupropion—obesity	7.73e-05	0.00106	CcSEcCtD
Maprotiline—Increased appetite—Topiramate—obesity	7.73e-05	0.00106	CcSEcCtD
Maprotiline—Tension—Sibutramine—obesity	7.72e-05	0.00106	CcSEcCtD
Maprotiline—Dysgeusia—Sibutramine—obesity	7.71e-05	0.00106	CcSEcCtD
Maprotiline—Menopausal symptoms—Topiramate—obesity	7.69e-05	0.00106	CcSEcCtD
Maprotiline—Vision blurred—Orlistat—obesity	7.66e-05	0.00105	CcSEcCtD
Maprotiline—Nervousness—Sibutramine—obesity	7.64e-05	0.00105	CcSEcCtD
Maprotiline—Vomiting—Cimetidine—obesity	7.64e-05	0.00105	CcSEcCtD
Maprotiline—Rash—Cimetidine—obesity	7.58e-05	0.00104	CcSEcCtD
Maprotiline—Dermatitis—Cimetidine—obesity	7.57e-05	0.00104	CcSEcCtD
Maprotiline—Headache—Cimetidine—obesity	7.53e-05	0.00103	CcSEcCtD
Maprotiline—Purpura—Topiramate—obesity	7.53e-05	0.00103	CcSEcCtD
Maprotiline—CYP2D6—endocrine gland—obesity	7.52e-05	0.00342	CbGeAlD
Maprotiline—Nausea—Diethylpropion—obesity	7.5e-05	0.00103	CcSEcCtD
Maprotiline—Erythema multiforme—Bupropion—obesity	7.45e-05	0.00102	CcSEcCtD
Maprotiline—HTR2A—liver—obesity	7.44e-05	0.00338	CbGeAlD
Maprotiline—Vision blurred—Sibutramine—obesity	7.42e-05	0.00102	CcSEcCtD
Maprotiline—Tremor—Sibutramine—obesity	7.37e-05	0.00101	CcSEcCtD
Maprotiline—Eye disorder—Bupropion—obesity	7.37e-05	0.00101	CcSEcCtD
Maprotiline—Tinnitus—Bupropion—obesity	7.35e-05	0.00101	CcSEcCtD
Maprotiline—Flushing—Bupropion—obesity	7.31e-05	0.00101	CcSEcCtD
Maprotiline—Cardiac disorder—Bupropion—obesity	7.31e-05	0.00101	CcSEcCtD
Maprotiline—Osteoarthritis—Topiramate—obesity	7.26e-05	0.000997	CcSEcCtD
Maprotiline—Agitation—Sibutramine—obesity	7.23e-05	0.000994	CcSEcCtD
Maprotiline—Disturbance in sexual arousal—Topiramate—obesity	7.2e-05	0.000989	CcSEcCtD
Maprotiline—Palpitations—Orlistat—obesity	7.19e-05	0.000987	CcSEcCtD
Maprotiline—Angiopathy—Bupropion—obesity	7.15e-05	0.000983	CcSEcCtD
Maprotiline—Nausea—Cimetidine—obesity	7.14e-05	0.000981	CcSEcCtD
Maprotiline—Mediastinal disorder—Bupropion—obesity	7.1e-05	0.000976	CcSEcCtD
Maprotiline—Psychotic disorder—Topiramate—obesity	7.09e-05	0.000974	CcSEcCtD
Maprotiline—Atomoxetine—HTR1B—obesity	7.08e-05	0.0424	CrCbGaD
Maprotiline—Syncope—Sibutramine—obesity	7.06e-05	0.00097	CcSEcCtD
Maprotiline—Convulsion—Orlistat—obesity	7.05e-05	0.000968	CcSEcCtD
Maprotiline—Leukopenia—Sibutramine—obesity	7.04e-05	0.000968	CcSEcCtD
Maprotiline—Arrhythmia—Bupropion—obesity	7.04e-05	0.000967	CcSEcCtD
Maprotiline—ABCB1—pituitary gland—obesity	6.99e-05	0.00317	CbGeAlD
Maprotiline—Alopecia—Bupropion—obesity	6.96e-05	0.000957	CcSEcCtD
Maprotiline—ABCB1—adipose tissue—obesity	6.96e-05	0.00316	CbGeAlD
Maprotiline—Palpitations—Sibutramine—obesity	6.96e-05	0.000956	CcSEcCtD
Maprotiline—Loss of consciousness—Sibutramine—obesity	6.92e-05	0.00095	CcSEcCtD
Maprotiline—Urinary retention—Topiramate—obesity	6.9e-05	0.000948	CcSEcCtD
Maprotiline—Anxiety—Orlistat—obesity	6.9e-05	0.000948	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	6.88e-05	0.000945	CcSEcCtD
Maprotiline—Malnutrition—Bupropion—obesity	6.86e-05	0.000943	CcSEcCtD
Maprotiline—Ataxia—Topiramate—obesity	6.83e-05	0.000938	CcSEcCtD
Maprotiline—Convulsion—Sibutramine—obesity	6.82e-05	0.000937	CcSEcCtD
Maprotiline—Hypertension—Sibutramine—obesity	6.79e-05	0.000934	CcSEcCtD
Maprotiline—CYP2D6—liver—obesity	6.78e-05	0.00308	CbGeAlD
Maprotiline—Dry mouth—Orlistat—obesity	6.77e-05	0.00093	CcSEcCtD
Maprotiline—Tension—Bupropion—obesity	6.73e-05	0.000925	CcSEcCtD
Maprotiline—Dysgeusia—Bupropion—obesity	6.72e-05	0.000923	CcSEcCtD
Maprotiline—Liver function test abnormal—Topiramate—obesity	6.7e-05	0.000921	CcSEcCtD
Maprotiline—Anxiety—Sibutramine—obesity	6.68e-05	0.000917	CcSEcCtD
Maprotiline—Nervousness—Bupropion—obesity	6.66e-05	0.000916	CcSEcCtD
Maprotiline—Oedema—Orlistat—obesity	6.64e-05	0.000912	CcSEcCtD
Maprotiline—Orthostatic hypotension—Topiramate—obesity	6.63e-05	0.000911	CcSEcCtD
Maprotiline—Infection—Orlistat—obesity	6.59e-05	0.000906	CcSEcCtD
Maprotiline—Breast disorder—Topiramate—obesity	6.56e-05	0.000901	CcSEcCtD
Maprotiline—Dry mouth—Sibutramine—obesity	6.55e-05	0.0009	CcSEcCtD
Maprotiline—ABCB1—digestive system—obesity	6.55e-05	0.00298	CbGeAlD
Maprotiline—Toxic epidermal necrolysis—Topiramate—obesity	6.54e-05	0.000898	CcSEcCtD
Maprotiline—Nervous system disorder—Orlistat—obesity	6.51e-05	0.000894	CcSEcCtD
Maprotiline—Confusional state—Sibutramine—obesity	6.48e-05	0.00089	CcSEcCtD
Maprotiline—Vision blurred—Bupropion—obesity	6.47e-05	0.000888	CcSEcCtD
Maprotiline—Skin disorder—Orlistat—obesity	6.45e-05	0.000886	CcSEcCtD
Maprotiline—Tremor—Bupropion—obesity	6.43e-05	0.000883	CcSEcCtD
Maprotiline—Oedema—Sibutramine—obesity	6.42e-05	0.000883	CcSEcCtD
Maprotiline—Hyperhidrosis—Orlistat—obesity	6.42e-05	0.000882	CcSEcCtD
Maprotiline—Muscular weakness—Topiramate—obesity	6.4e-05	0.00088	CcSEcCtD
Maprotiline—Infection—Sibutramine—obesity	6.38e-05	0.000877	CcSEcCtD
Maprotiline—Shock—Sibutramine—obesity	6.32e-05	0.000868	CcSEcCtD
Maprotiline—Agitation—Bupropion—obesity	6.31e-05	0.000866	CcSEcCtD
Maprotiline—Thrombocytopenia—Sibutramine—obesity	6.29e-05	0.000864	CcSEcCtD
Maprotiline—Dysphagia—Topiramate—obesity	6.27e-05	0.000862	CcSEcCtD
Maprotiline—Tachycardia—Sibutramine—obesity	6.27e-05	0.000861	CcSEcCtD
Maprotiline—ABCB1—adrenal gland—obesity	6.24e-05	0.00284	CbGeAlD
Maprotiline—Skin disorder—Sibutramine—obesity	6.24e-05	0.000857	CcSEcCtD
Maprotiline—Eosinophilia—Topiramate—obesity	6.21e-05	0.000853	CcSEcCtD
Maprotiline—Hyperhidrosis—Sibutramine—obesity	6.21e-05	0.000853	CcSEcCtD
Maprotiline—Syncope—Bupropion—obesity	6.15e-05	0.000845	CcSEcCtD
Maprotiline—Leukopenia—Bupropion—obesity	6.14e-05	0.000844	CcSEcCtD
Maprotiline—Sweating increased—Topiramate—obesity	6.11e-05	0.00084	CcSEcCtD
Maprotiline—Palpitations—Bupropion—obesity	6.06e-05	0.000833	CcSEcCtD
Maprotiline—Loss of consciousness—Bupropion—obesity	6.03e-05	0.000829	CcSEcCtD
Maprotiline—Insomnia—Orlistat—obesity	6e-05	0.000825	CcSEcCtD
Maprotiline—Hypotension—Sibutramine—obesity	6e-05	0.000825	CcSEcCtD
Maprotiline—Paraesthesia—Orlistat—obesity	5.96e-05	0.000819	CcSEcCtD
Maprotiline—Pancytopenia—Topiramate—obesity	5.96e-05	0.000819	CcSEcCtD
Maprotiline—Convulsion—Bupropion—obesity	5.94e-05	0.000817	CcSEcCtD
Maprotiline—Desipramine—SLC22A1—obesity	5.94e-05	0.0356	CrCbGaD
Maprotiline—Hypertension—Bupropion—obesity	5.92e-05	0.000814	CcSEcCtD
Maprotiline—Dyspepsia—Orlistat—obesity	5.84e-05	0.000803	CcSEcCtD
Maprotiline—Anxiety—Bupropion—obesity	5.82e-05	0.0008	CcSEcCtD
Maprotiline—Insomnia—Sibutramine—obesity	5.81e-05	0.000798	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	5.8e-05	0.000797	CcSEcCtD
Maprotiline—Pollakiuria—Topiramate—obesity	5.8e-05	0.000796	CcSEcCtD
Maprotiline—Erectile dysfunction—Topiramate—obesity	5.78e-05	0.000794	CcSEcCtD
Maprotiline—Atomoxetine—HTR2C—obesity	5.77e-05	0.0346	CrCbGaD
Maprotiline—Paraesthesia—Sibutramine—obesity	5.77e-05	0.000792	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Orlistat—obesity	5.73e-05	0.000787	CcSEcCtD
Maprotiline—Photosensitivity reaction—Topiramate—obesity	5.73e-05	0.000787	CcSEcCtD
Maprotiline—Fatigue—Orlistat—obesity	5.72e-05	0.000786	CcSEcCtD
Maprotiline—Dry mouth—Bupropion—obesity	5.71e-05	0.000785	CcSEcCtD
Maprotiline—Somnolence—Sibutramine—obesity	5.71e-05	0.000785	CcSEcCtD
Maprotiline—Weight increased—Topiramate—obesity	5.71e-05	0.000784	CcSEcCtD
Maprotiline—Weight decreased—Topiramate—obesity	5.68e-05	0.00078	CcSEcCtD
Maprotiline—Dyspepsia—Sibutramine—obesity	5.65e-05	0.000777	CcSEcCtD
Maprotiline—Confusional state—Bupropion—obesity	5.65e-05	0.000776	CcSEcCtD
Maprotiline—Oedema—Bupropion—obesity	5.6e-05	0.000769	CcSEcCtD
Maprotiline—Infestation—Topiramate—obesity	5.59e-05	0.000769	CcSEcCtD
Maprotiline—Infestation NOS—Topiramate—obesity	5.59e-05	0.000769	CcSEcCtD
Maprotiline—Infection—Bupropion—obesity	5.56e-05	0.000764	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Topiramate—obesity	5.55e-05	0.000762	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Sibutramine—obesity	5.55e-05	0.000762	CcSEcCtD
Maprotiline—Shock—Bupropion—obesity	5.51e-05	0.000757	CcSEcCtD
Maprotiline—Constipation—Sibutramine—obesity	5.49e-05	0.000755	CcSEcCtD
Maprotiline—Nervous system disorder—Bupropion—obesity	5.49e-05	0.000755	CcSEcCtD
Maprotiline—Neuropathy peripheral—Topiramate—obesity	5.48e-05	0.000753	CcSEcCtD
Maprotiline—Thrombocytopenia—Bupropion—obesity	5.48e-05	0.000753	CcSEcCtD
Maprotiline—Feeling abnormal—Orlistat—obesity	5.47e-05	0.000751	CcSEcCtD
Maprotiline—Tachycardia—Bupropion—obesity	5.47e-05	0.000751	CcSEcCtD
Maprotiline—Stomatitis—Topiramate—obesity	5.45e-05	0.000749	CcSEcCtD
Maprotiline—Skin disorder—Bupropion—obesity	5.44e-05	0.000747	CcSEcCtD
Maprotiline—Gastrointestinal pain—Orlistat—obesity	5.43e-05	0.000746	CcSEcCtD
Maprotiline—Hyperhidrosis—Bupropion—obesity	5.41e-05	0.000744	CcSEcCtD
Maprotiline—ABCB1—endocrine gland—obesity	5.41e-05	0.00246	CbGeAlD
Maprotiline—Feeling abnormal—Sibutramine—obesity	5.29e-05	0.000727	CcSEcCtD
Maprotiline—Urticaria—Orlistat—obesity	5.27e-05	0.000724	CcSEcCtD
Maprotiline—Gastrointestinal pain—Sibutramine—obesity	5.25e-05	0.000722	CcSEcCtD
Maprotiline—Body temperature increased—Orlistat—obesity	5.25e-05	0.000721	CcSEcCtD
Maprotiline—Abdominal pain—Orlistat—obesity	5.25e-05	0.000721	CcSEcCtD
Maprotiline—Hypotension—Bupropion—obesity	5.23e-05	0.000719	CcSEcCtD
Maprotiline—Agranulocytosis—Topiramate—obesity	5.22e-05	0.000717	CcSEcCtD
Maprotiline—Urticaria—Sibutramine—obesity	5.1e-05	0.000701	CcSEcCtD
Maprotiline—Abdominal pain—Sibutramine—obesity	5.08e-05	0.000698	CcSEcCtD
Maprotiline—Body temperature increased—Sibutramine—obesity	5.08e-05	0.000698	CcSEcCtD
Maprotiline—Insomnia—Bupropion—obesity	5.06e-05	0.000696	CcSEcCtD
Maprotiline—Nortriptyline—HTR2C—obesity	5.04e-05	0.0302	CrCbGaD
Maprotiline—Imipramine—SLC22A1—obesity	5.03e-05	0.0302	CrCbGaD
Maprotiline—Paraesthesia—Bupropion—obesity	5.03e-05	0.000691	CcSEcCtD
Maprotiline—Hepatitis—Topiramate—obesity	5.02e-05	0.00069	CcSEcCtD
Maprotiline—Hallucination—Topiramate—obesity	5e-05	0.000686	CcSEcCtD
Maprotiline—Hypoaesthesia—Topiramate—obesity	5e-05	0.000686	CcSEcCtD
Maprotiline—Somnolence—Bupropion—obesity	4.98e-05	0.000684	CcSEcCtD
Maprotiline—Urinary tract disorder—Topiramate—obesity	4.96e-05	0.000681	CcSEcCtD
Maprotiline—Dyspepsia—Bupropion—obesity	4.93e-05	0.000677	CcSEcCtD
Maprotiline—Urethral disorder—Topiramate—obesity	4.92e-05	0.000676	CcSEcCtD
Maprotiline—ABCB1—liver—obesity	4.88e-05	0.00222	CbGeAlD
Maprotiline—Gastrointestinal disorder—Bupropion—obesity	4.83e-05	0.000664	CcSEcCtD
Maprotiline—Fatigue—Bupropion—obesity	4.83e-05	0.000663	CcSEcCtD
Maprotiline—Constipation—Bupropion—obesity	4.79e-05	0.000658	CcSEcCtD
Maprotiline—Atomoxetine—SLC6A4—obesity	4.78e-05	0.0286	CrCbGaD
Maprotiline—Asthenia—Orlistat—obesity	4.76e-05	0.000654	CcSEcCtD
Maprotiline—Erythema multiforme—Topiramate—obesity	4.75e-05	0.000652	CcSEcCtD
Maprotiline—Pruritus—Orlistat—obesity	4.7e-05	0.000645	CcSEcCtD
Maprotiline—Eye disorder—Topiramate—obesity	4.69e-05	0.000645	CcSEcCtD
Maprotiline—Tinnitus—Topiramate—obesity	4.68e-05	0.000643	CcSEcCtD
Maprotiline—Flushing—Topiramate—obesity	4.66e-05	0.00064	CcSEcCtD
Maprotiline—Cardiac disorder—Topiramate—obesity	4.66e-05	0.00064	CcSEcCtD
Maprotiline—Feeling abnormal—Bupropion—obesity	4.61e-05	0.000634	CcSEcCtD
Maprotiline—Asthenia—Sibutramine—obesity	4.61e-05	0.000633	CcSEcCtD
Maprotiline—Gastrointestinal pain—Bupropion—obesity	4.58e-05	0.000629	CcSEcCtD
Maprotiline—Angiopathy—Topiramate—obesity	4.56e-05	0.000626	CcSEcCtD
Maprotiline—Pruritus—Sibutramine—obesity	4.54e-05	0.000624	CcSEcCtD
Maprotiline—Diarrhoea—Orlistat—obesity	4.54e-05	0.000624	CcSEcCtD
Maprotiline—Mediastinal disorder—Topiramate—obesity	4.53e-05	0.000622	CcSEcCtD
Maprotiline—Desipramine—ADRB1—obesity	4.5e-05	0.027	CrCbGaD
Maprotiline—Urticaria—Bupropion—obesity	4.45e-05	0.000611	CcSEcCtD
Maprotiline—Alopecia—Topiramate—obesity	4.44e-05	0.00061	CcSEcCtD
Maprotiline—Body temperature increased—Bupropion—obesity	4.43e-05	0.000608	CcSEcCtD
Maprotiline—Abdominal pain—Bupropion—obesity	4.43e-05	0.000608	CcSEcCtD
Maprotiline—Diarrhoea—Sibutramine—obesity	4.39e-05	0.000604	CcSEcCtD
Maprotiline—Dizziness—Orlistat—obesity	4.39e-05	0.000603	CcSEcCtD
Maprotiline—Malnutrition—Topiramate—obesity	4.37e-05	0.000601	CcSEcCtD
Maprotiline—Tension—Topiramate—obesity	4.29e-05	0.000589	CcSEcCtD
Maprotiline—Dysgeusia—Topiramate—obesity	4.28e-05	0.000588	CcSEcCtD
Maprotiline—Dizziness—Sibutramine—obesity	4.25e-05	0.000584	CcSEcCtD
Maprotiline—Nervousness—Topiramate—obesity	4.25e-05	0.000583	CcSEcCtD
Maprotiline—Vomiting—Orlistat—obesity	4.22e-05	0.00058	CcSEcCtD
Maprotiline—Rash—Orlistat—obesity	4.18e-05	0.000575	CcSEcCtD
Maprotiline—Dermatitis—Orlistat—obesity	4.18e-05	0.000574	CcSEcCtD
Maprotiline—Nortriptyline—SLC6A4—obesity	4.18e-05	0.025	CrCbGaD
Maprotiline—Headache—Orlistat—obesity	4.16e-05	0.000571	CcSEcCtD
Maprotiline—Nortriptyline—DRD2—obesity	4.15e-05	0.0249	CrCbGaD
Maprotiline—Desipramine—HTR2C—obesity	4.15e-05	0.0249	CrCbGaD
Maprotiline—Vision blurred—Topiramate—obesity	4.12e-05	0.000566	CcSEcCtD
Maprotiline—Tremor—Topiramate—obesity	4.1e-05	0.000563	CcSEcCtD
Maprotiline—Vomiting—Sibutramine—obesity	4.08e-05	0.000561	CcSEcCtD
Maprotiline—Rash—Sibutramine—obesity	4.05e-05	0.000556	CcSEcCtD
Maprotiline—Dermatitis—Sibutramine—obesity	4.05e-05	0.000556	CcSEcCtD
Maprotiline—Headache—Sibutramine—obesity	4.02e-05	0.000553	CcSEcCtD
Maprotiline—Asthenia—Bupropion—obesity	4.02e-05	0.000552	CcSEcCtD
Maprotiline—Agitation—Topiramate—obesity	4.02e-05	0.000552	CcSEcCtD
Maprotiline—Nortriptyline—CYP2E1—obesity	4e-05	0.024	CrCbGaD
Maprotiline—Pruritus—Bupropion—obesity	3.96e-05	0.000544	CcSEcCtD
Maprotiline—Nausea—Orlistat—obesity	3.94e-05	0.000542	CcSEcCtD
Maprotiline—Syncope—Topiramate—obesity	3.92e-05	0.000539	CcSEcCtD
Maprotiline—Leukopenia—Topiramate—obesity	3.91e-05	0.000538	CcSEcCtD
Maprotiline—Palpitations—Topiramate—obesity	3.86e-05	0.000531	CcSEcCtD
Maprotiline—Loss of consciousness—Topiramate—obesity	3.84e-05	0.000528	CcSEcCtD
Maprotiline—Diarrhoea—Bupropion—obesity	3.83e-05	0.000526	CcSEcCtD
Maprotiline—Nausea—Sibutramine—obesity	3.82e-05	0.000524	CcSEcCtD
Maprotiline—Desipramine—ADRB2—obesity	3.79e-05	0.0227	CrCbGaD
Maprotiline—Convulsion—Topiramate—obesity	3.79e-05	0.00052	CcSEcCtD
Maprotiline—Hypertension—Topiramate—obesity	3.77e-05	0.000519	CcSEcCtD
Maprotiline—Anxiety—Topiramate—obesity	3.71e-05	0.00051	CcSEcCtD
Maprotiline—Dizziness—Bupropion—obesity	3.7e-05	0.000509	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	3.7e-05	0.000508	CcSEcCtD
Maprotiline—Atomoxetine—HTR2A—obesity	3.68e-05	0.022	CrCbGaD
Maprotiline—Dry mouth—Topiramate—obesity	3.64e-05	0.0005	CcSEcCtD
Maprotiline—Confusional state—Topiramate—obesity	3.6e-05	0.000494	CcSEcCtD
Maprotiline—Oedema—Topiramate—obesity	3.57e-05	0.00049	CcSEcCtD
Maprotiline—Vomiting—Bupropion—obesity	3.56e-05	0.000489	CcSEcCtD
Maprotiline—Infection—Topiramate—obesity	3.54e-05	0.000487	CcSEcCtD
Maprotiline—Rash—Bupropion—obesity	3.53e-05	0.000485	CcSEcCtD
Maprotiline—Dermatitis—Bupropion—obesity	3.53e-05	0.000485	CcSEcCtD
Maprotiline—Imipramine—HTR2C—obesity	3.52e-05	0.0211	CrCbGaD
Maprotiline—Shock—Topiramate—obesity	3.51e-05	0.000482	CcSEcCtD
Maprotiline—Headache—Bupropion—obesity	3.51e-05	0.000482	CcSEcCtD
Maprotiline—Nervous system disorder—Topiramate—obesity	3.5e-05	0.000481	CcSEcCtD
Maprotiline—Thrombocytopenia—Topiramate—obesity	3.49e-05	0.00048	CcSEcCtD
Maprotiline—Tachycardia—Topiramate—obesity	3.48e-05	0.000478	CcSEcCtD
Maprotiline—Skin disorder—Topiramate—obesity	3.47e-05	0.000476	CcSEcCtD
Maprotiline—Hyperhidrosis—Topiramate—obesity	3.45e-05	0.000474	CcSEcCtD
Maprotiline—Desipramine—SLC6A4—obesity	3.44e-05	0.0206	CrCbGaD
Maprotiline—Desipramine—DRD2—obesity	3.42e-05	0.0205	CrCbGaD
Maprotiline—Hypotension—Topiramate—obesity	3.33e-05	0.000458	CcSEcCtD
Maprotiline—Nausea—Bupropion—obesity	3.33e-05	0.000457	CcSEcCtD
Maprotiline—Desipramine—CYP2E1—obesity	3.29e-05	0.0197	CrCbGaD
Maprotiline—Insomnia—Topiramate—obesity	3.23e-05	0.000443	CcSEcCtD
Maprotiline—Nortriptyline—HTR2A—obesity	3.21e-05	0.0192	CrCbGaD
Maprotiline—Paraesthesia—Topiramate—obesity	3.2e-05	0.00044	CcSEcCtD
Maprotiline—Somnolence—Topiramate—obesity	3.17e-05	0.000436	CcSEcCtD
Maprotiline—Dyspepsia—Topiramate—obesity	3.14e-05	0.000431	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Topiramate—obesity	3.08e-05	0.000423	CcSEcCtD
Maprotiline—Fatigue—Topiramate—obesity	3.08e-05	0.000423	CcSEcCtD
Maprotiline—Constipation—Topiramate—obesity	3.05e-05	0.000419	CcSEcCtD
Maprotiline—Feeling abnormal—Topiramate—obesity	2.94e-05	0.000404	CcSEcCtD
Maprotiline—Gastrointestinal pain—Topiramate—obesity	2.92e-05	0.000401	CcSEcCtD
Maprotiline—Imipramine—SLC6A4—obesity	2.92e-05	0.0175	CrCbGaD
Maprotiline—Imipramine—DRD2—obesity	2.9e-05	0.0174	CrCbGaD
Maprotiline—Urticaria—Topiramate—obesity	2.83e-05	0.000389	CcSEcCtD
Maprotiline—Abdominal pain—Topiramate—obesity	2.82e-05	0.000388	CcSEcCtD
Maprotiline—Body temperature increased—Topiramate—obesity	2.82e-05	0.000388	CcSEcCtD
Maprotiline—Imipramine—CYP2E1—obesity	2.79e-05	0.0167	CrCbGaD
Maprotiline—Desipramine—HTR2A—obesity	2.64e-05	0.0158	CrCbGaD
Maprotiline—Asthenia—Topiramate—obesity	2.56e-05	0.000352	CcSEcCtD
Maprotiline—Pruritus—Topiramate—obesity	2.52e-05	0.000347	CcSEcCtD
Maprotiline—Diarrhoea—Topiramate—obesity	2.44e-05	0.000335	CcSEcCtD
Maprotiline—Dizziness—Topiramate—obesity	2.36e-05	0.000324	CcSEcCtD
Maprotiline—Vomiting—Topiramate—obesity	2.27e-05	0.000312	CcSEcCtD
Maprotiline—Rash—Topiramate—obesity	2.25e-05	0.000309	CcSEcCtD
Maprotiline—Dermatitis—Topiramate—obesity	2.25e-05	0.000309	CcSEcCtD
Maprotiline—Imipramine—HTR2A—obesity	2.24e-05	0.0134	CrCbGaD
Maprotiline—Headache—Topiramate—obesity	2.23e-05	0.000307	CcSEcCtD
Maprotiline—Nortriptyline—ALB—obesity	2.2e-05	0.0132	CrCbGaD
Maprotiline—Nausea—Topiramate—obesity	2.12e-05	0.000291	CcSEcCtD
Maprotiline—CYP2D6—Metabolism—LPL—obesity	8.83e-07	1.59e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—POMC—obesity	8.8e-07	1.59e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CCL2—obesity	8.77e-07	1.58e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IGF1—obesity	8.77e-07	1.58e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—AKT2—obesity	8.76e-07	1.58e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—INS—obesity	8.75e-07	1.58e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CCL2—obesity	8.75e-07	1.58e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCL2—obesity	8.73e-07	1.57e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—STAT3—obesity	8.71e-07	1.57e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCL2—obesity	8.7e-07	1.57e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IGF1—obesity	8.62e-07	1.56e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MAPK8—obesity	8.62e-07	1.55e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—AKT2—obesity	8.62e-07	1.55e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCL2—obesity	8.61e-07	1.55e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GPX1—obesity	8.61e-07	1.55e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IGF1—obesity	8.61e-07	1.55e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—AKT2—obesity	8.6e-07	1.55e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—AKT1—obesity	8.6e-07	1.55e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IGF1—obesity	8.58e-07	1.55e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—PIK3CA—obesity	8.58e-07	1.55e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—AKT2—obesity	8.57e-07	1.55e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—PIK3CB—obesity	8.56e-07	1.54e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IGF1—obesity	8.55e-07	1.54e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—AKT2—obesity	8.54e-07	1.54e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—PTGS2—obesity	8.48e-07	1.53e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IGF1—obesity	8.47e-07	1.53e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—AKT2—obesity	8.46e-07	1.53e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—MTHFR—obesity	8.43e-07	1.52e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PIK3CD—obesity	8.42e-07	1.52e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CD36—obesity	8.39e-07	1.51e-05	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—PIK3CA—obesity	8.34e-07	1.5e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—COMT—obesity	8.33e-07	1.5e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—SERPINE1—obesity	8.32e-07	1.5e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MTOR—obesity	8.31e-07	1.5e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—PIK3CB—obesity	8.31e-07	1.5e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PIK3CD—obesity	8.28e-07	1.49e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PPARA—obesity	8.28e-07	1.49e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PIK3CD—obesity	8.26e-07	1.49e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PIK3CD—obesity	8.24e-07	1.49e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—STAT3—obesity	8.23e-07	1.48e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PPARGC1A—obesity	8.21e-07	1.48e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GNB3—obesity	8.21e-07	1.48e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PIK3CD—obesity	8.21e-07	1.48e-05	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—PIK3CA—obesity	8.2e-07	1.48e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—SERPINE1—obesity	8.19e-07	1.48e-05	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—PIK3CA—obesity	8.18e-07	1.48e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—HMOX1—obesity	8.18e-07	1.47e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—SERPINE1—obesity	8.17e-07	1.47e-05	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—PIK3CA—obesity	8.16e-07	1.47e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—SERPINE1—obesity	8.15e-07	1.47e-05	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—PIK3CA—obesity	8.13e-07	1.47e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PIK3CD—obesity	8.13e-07	1.47e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—SERPINE1—obesity	8.12e-07	1.46e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TYK2—obesity	8.1e-07	1.46e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—MYC—obesity	8.1e-07	1.46e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TGFB1—obesity	8.08e-07	1.46e-05	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—PIK3CA—obesity	8.05e-07	1.45e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—SERPINE1—obesity	8.04e-07	1.45e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—RHOA—obesity	8.03e-07	1.45e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—AGT—obesity	8.01e-07	1.45e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GNAS—obesity	8e-07	1.44e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TYK2—obesity	7.97e-07	1.44e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TYK2—obesity	7.95e-07	1.43e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—MTHFR—obesity	7.95e-07	1.43e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PIK3R1—obesity	7.95e-07	1.43e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—NOS3—obesity	7.95e-07	1.43e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TYK2—obesity	7.92e-07	1.43e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—RHOA—obesity	7.9e-07	1.42e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TYK2—obesity	7.9e-07	1.42e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—RHOA—obesity	7.88e-07	1.42e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—STAT3—obesity	7.88e-07	1.42e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—RHOA—obesity	7.86e-07	1.42e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—APOE—obesity	7.85e-07	1.42e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—RHOA—obesity	7.83e-07	1.41e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—APOB—obesity	7.83e-07	1.41e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TYK2—obesity	7.82e-07	1.41e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—NOS3—obesity	7.82e-07	1.41e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PIK3R1—obesity	7.82e-07	1.41e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—NOS3—obesity	7.8e-07	1.41e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PIK3R1—obesity	7.8e-07	1.41e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PPARA—obesity	7.8e-07	1.41e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CAV1—obesity	7.78e-07	1.4e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PIK3R1—obesity	7.78e-07	1.4e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—NOS3—obesity	7.78e-07	1.4e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—APOA1—obesity	7.76e-07	1.4e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—RHOA—obesity	7.76e-07	1.4e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PIK3R1—obesity	7.75e-07	1.4e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—NOS3—obesity	7.75e-07	1.4e-05	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—AKT1—obesity	7.72e-07	1.39e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PIK3R1—obesity	7.68e-07	1.38e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NOS3—obesity	7.68e-07	1.38e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—MYC—obesity	7.65e-07	1.38e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TGFB1—obesity	7.63e-07	1.38e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—IL6—obesity	7.6e-07	1.37e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—PIK3CA—obesity	7.57e-07	1.36e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—AGT—obesity	7.55e-07	1.36e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—LPL—obesity	7.48e-07	1.35e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—PIK3CA—obesity	7.45e-07	1.34e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—PIK3CA—obesity	7.43e-07	1.34e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—PIK3CA—obesity	7.41e-07	1.34e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—APOE—obesity	7.4e-07	1.33e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—PIK3CA—obesity	7.38e-07	1.33e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MTOR—obesity	7.34e-07	1.32e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PIK3CB—obesity	7.34e-07	1.32e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CAV1—obesity	7.33e-07	1.32e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MYC—obesity	7.32e-07	1.32e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—APOA1—obesity	7.32e-07	1.32e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—PIK3CA—obesity	7.31e-07	1.32e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TGFB1—obesity	7.3e-07	1.32e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GPX1—obesity	7.3e-07	1.32e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MMP9—obesity	7.22e-07	1.3e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MTOR—obesity	7.22e-07	1.3e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PIK3CB—obesity	7.22e-07	1.3e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MTOR—obesity	7.2e-07	1.3e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PIK3CB—obesity	7.2e-07	1.3e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MTOR—obesity	7.18e-07	1.29e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PIK3CB—obesity	7.18e-07	1.29e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PIK3CB—obesity	7.16e-07	1.29e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MTOR—obesity	7.16e-07	1.29e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CD36—obesity	7.11e-07	1.28e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PIK3CG—obesity	7.09e-07	1.28e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MTOR—obesity	7.09e-07	1.28e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PIK3CB—obesity	7.09e-07	1.28e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MAPK8—obesity	7.03e-07	1.27e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—AKT1—obesity	7.01e-07	1.26e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—PIK3CA—obesity	6.87e-07	1.24e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PPARG—obesity	6.84e-07	1.23e-05	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—AKT1—obesity	6.81e-07	1.23e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—POMC—obesity	6.75e-07	1.22e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—MTHFR—obesity	6.73e-07	1.21e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—INS—obesity	6.71e-07	1.21e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—IL6—obesity	6.7e-07	1.21e-05	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—AKT1—obesity	6.7e-07	1.21e-05	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—AKT1—obesity	6.69e-07	1.21e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PIK3CG—obesity	6.68e-07	1.2e-05	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—AKT1—obesity	6.66e-07	1.2e-05	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—AKT1—obesity	6.64e-07	1.2e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PPARA—obesity	6.61e-07	1.19e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—IL6—obesity	6.6e-07	1.19e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—IL6—obesity	6.58e-07	1.19e-05	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—AKT1—obesity	6.58e-07	1.19e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—IL6—obesity	6.56e-07	1.18e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—IL6—obesity	6.54e-07	1.18e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—PIK3CA—obesity	6.49e-07	1.17e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—IL6—obesity	6.48e-07	1.17e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PPARG—obesity	6.45e-07	1.16e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—STAT3—obesity	6.42e-07	1.16e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—AGT—obesity	6.4e-07	1.15e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MMP9—obesity	6.38e-07	1.15e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—POMC—obesity	6.36e-07	1.15e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—INS—obesity	6.32e-07	1.14e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MMP9—obesity	6.27e-07	1.13e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—APOE—obesity	6.27e-07	1.13e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MMP9—obesity	6.26e-07	1.13e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MMP9—obesity	6.24e-07	1.13e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PIK3CD—obesity	6.23e-07	1.12e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MMP9—obesity	6.22e-07	1.12e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—PIK3CA—obesity	6.22e-07	1.12e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CAV1—obesity	6.21e-07	1.12e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MAPK8—obesity	6.2e-07	1.12e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—APOA1—obesity	6.2e-07	1.12e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—AKT1—obesity	6.18e-07	1.11e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MMP9—obesity	6.16e-07	1.11e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—ALB—obesity	6.15e-07	1.11e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MAPK8—obesity	6.1e-07	1.1e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MAPK8—obesity	6.09e-07	1.1e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IL6—obesity	6.09e-07	1.1e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—AKT1—obesity	6.08e-07	1.1e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—AKT1—obesity	6.07e-07	1.09e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MAPK8—obesity	6.07e-07	1.09e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—AKT1—obesity	6.05e-07	1.09e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MAPK8—obesity	6.05e-07	1.09e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—AKT1—obesity	6.03e-07	1.09e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MAPK8—obesity	5.99e-07	1.08e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—AKT1—obesity	5.97e-07	1.08e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MYC—obesity	5.97e-07	1.08e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TGFB1—obesity	5.95e-07	1.07e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	5.93e-07	1.07e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PIK3R1—obesity	5.88e-07	1.06e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—NOS3—obesity	5.88e-07	1.06e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PIK3CD—obesity	5.87e-07	1.06e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ALB—obesity	5.8e-07	1.04e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IL6—obesity	5.75e-07	1.04e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—STAT3—obesity	5.67e-07	1.02e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PIK3CG—obesity	5.66e-07	1.02e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—AKT1—obesity	5.61e-07	1.01e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—STAT3—obesity	5.58e-07	1.01e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—STAT3—obesity	5.57e-07	1e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—STAT3—obesity	5.55e-07	1e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PIK3R1—obesity	5.54e-07	1e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—NOS3—obesity	5.54e-07	1e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—STAT3—obesity	5.53e-07	9.97e-06	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IL6—obesity	5.5e-07	9.92e-06	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—STAT3—obesity	5.48e-07	9.87e-06	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PPARG—obesity	5.46e-07	9.84e-06	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PIK3CB—obesity	5.43e-07	9.79e-06	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—POMC—obesity	5.39e-07	9.71e-06	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PTGS2—obesity	5.38e-07	9.7e-06	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—INS—obesity	5.36e-07	9.66e-06	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—AKT1—obesity	5.3e-07	9.56e-06	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MYC—obesity	5.27e-07	9.5e-06	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TGFB1—obesity	5.25e-07	9.47e-06	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—PIK3CA—obesity	5.22e-07	9.41e-06	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MYC—obesity	5.18e-07	9.35e-06	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MYC—obesity	5.17e-07	9.33e-06	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TGFB1—obesity	5.17e-07	9.32e-06	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TGFB1—obesity	5.16e-07	9.3e-06	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MYC—obesity	5.16e-07	9.3e-06	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TGFB1—obesity	5.14e-07	9.27e-06	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MYC—obesity	5.14e-07	9.27e-06	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TGFB1—obesity	5.13e-07	9.24e-06	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PIK3CB—obesity	5.12e-07	9.23e-06	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MYC—obesity	5.09e-07	9.18e-06	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—AKT1—obesity	5.08e-07	9.15e-06	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TGFB1—obesity	5.08e-07	9.15e-06	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PTGS2—obesity	5.07e-07	9.14e-06	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—PIK3CA—obesity	5.07e-07	9.14e-06	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PIK3CD—obesity	4.97e-07	8.97e-06	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ALB—obesity	4.91e-07	8.85e-06	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—NOS3—obesity	4.7e-07	8.47e-06	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PIK3R1—obesity	4.7e-07	8.47e-06	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL6—obesity	4.49e-07	8.09e-06	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PIK3CA—obesity	4.47e-07	8.06e-06	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PIK3CA—obesity	4.4e-07	7.93e-06	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PIK3CA—obesity	4.39e-07	7.92e-06	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PIK3CA—obesity	4.38e-07	7.89e-06	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PIK3CA—obesity	4.36e-07	7.87e-06	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PIK3CB—obesity	4.34e-07	7.82e-06	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PIK3CA—obesity	4.32e-07	7.79e-06	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PTGS2—obesity	4.3e-07	7.74e-06	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—AKT1—obesity	4.26e-07	7.68e-06	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—AKT1—obesity	4.14e-07	7.46e-06	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL6—obesity	3.96e-07	7.14e-06	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL6—obesity	3.9e-07	7.02e-06	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL6—obesity	3.89e-07	7.01e-06	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL6—obesity	3.88e-07	6.99e-06	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL6—obesity	3.86e-07	6.96e-06	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL6—obesity	3.83e-07	6.9e-06	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—AKT1—obesity	3.65e-07	6.59e-06	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—AKT1—obesity	3.59e-07	6.48e-06	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—AKT1—obesity	3.59e-07	6.47e-06	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—AKT1—obesity	3.58e-07	6.45e-06	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—AKT1—obesity	3.56e-07	6.43e-06	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—AKT1—obesity	3.53e-07	6.36e-06	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PIK3CA—obesity	3.31e-07	5.97e-06	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PIK3CA—obesity	3.12e-07	5.62e-06	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—AKT1—obesity	2.7e-07	4.88e-06	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PIK3CA—obesity	2.64e-07	4.76e-06	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—AKT1—obesity	2.55e-07	4.59e-06	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—AKT1—obesity	2.16e-07	3.89e-06	CbGpPWpGaD
